
MRI-before-biopsy could reshape prostate cancer screening, but uptake is uneven
Pre-biopsy MRI is transforming prostate cancer detection by guiding targeted biopsies and potentially reducing overdiagnosis and biopsy-related complications, but US adoption lags Europe and experts remain split on MRI-targeted biopsy alone versus combining it with systematic biopsies, due to training gaps, access disparities, and financial incentives.













